Search Results - "Dehkordi, Farnaz Farzaneh"

Investigating the impact of Tocilizumab, Sarilumab, and Anakinra on clinical outcomes in COVID-19: A systematic review and meta-analysis by Jafari Abarghan, Yousef, Heiat, Mohammad, Jahangiri, Abolfazl, Hossein Peypar, Mohammad, Abdorrashidi, Mahdi, Tohidinia, Amirmohammad, Salesi, Mahmood, Tajik, Shahrzad, Farzaneh Dehkordi, Farnaz, Sedighian, Hamid

“…Monoclonal antibodies (mAbs) are currently under investigation as a potential therapeutic option for COVID-19. Clinical trials are examining their efficacy in…”
Get full text

Green synthesis of bimetallic ZnO–CuO nanoparticles and their cytotoxicity properties by Cao, Yan, Dhahad, Hayder A., El-Shorbagy, M. A., Alijani, Hajar Q., Zakeri, Mana, Heydari, Abolfazl, Bahonar, Ehsan, Slouf, Miroslav, Khatami, Mehrdad, Naderifar, Mahin, Iravani, Siavash, Khatami, Sanaz, Dehkordi, Farnaz Farzaneh

“…In this study, a simple and green strategy was reported to prepare bimetallic nanoparticles (NPs) by the combination of zinc oxide (ZnO) and copper oxide (CuO)…”
Get full text

Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles by Abed, Atena, Derakhshan, Maryam, Karimi, Merat, Shirazinia, Matin, Mahjoubin-Tehran, Maryam, Homayonfal, Mina, Hamblin, Michael R, Mirzaei, Seyed Abbas, Soleimanpour, Hamidreza, Dehghani, Sadegh, Dehkordi, Farnaz Farzaneh, Mirzaei, Hamed

“…Cancer is the main cause of morbidity and mortality worldwide, excluding infectious disease. Because of their lack of specificity in chemotherapy agents are…”
Get full text

Association of Fibroblast Growth Factor (Fgf-21) as a Screening Biomarker for Chronic Progressive External Ophthalmoplesia by Dehkordi, Farnaz Farzaneh, Houshmand, Massoud, Sadeghizadeh, Majid, Kashkouli, Mohsen Bahmani, Javadi, Gholamreza

“…Purpose: To investigate whether or not fibroblast growth factor (FGF-21) can be used as a screening biomarker in chronic progressive external ophthalmoplesia…”
Get full text